July 2007

 

The ISPOR eBULLETIN provides updates of recent ISPOR activities and events. For detailed information on ISPOR activities, members are encouraged to go to: www.ispor.org. Please share these new ISPOR activities with your colleagues.

ISPOR Board of Directors 2007-2008
The 2007-2008 ISPOR Board of Directors took office on July 1, 2007. The Board members are as follows: 2007-2008 President Diana Brixner PhD; 2007-2008 President-elect Chris L. Pashos, PhD, 2007-2008 Past President Michael F. Drummond PhD, 2006-2008 Director Marc Berger MD, 2007-2009 Director Lou Garrison, PhD, 2006-2008 Director Shu-Chen Li PhD, 2006-2008 Director Uwe Siebert MD, 2007-2009 Director Richard J. Willke PhD, 2007-2010 Treasurer Karen Rascati RPh, PhD, and ISPOR Founding Executive Director Marilyn Dix Smith RPh, PhD.  For more information, see:
ISPOR Board of Directors>>

 

ISPOR 1st Latin America Conference

The ISPOR 1st Latin America Conference, "Current and Future Perspectives of Pharmacoeconomics and Outcomes Research in Latin America," will be held 9-11 September 2007, Hilton Cartagena Hotel and Convention Center, Cartagena, Columbia. For more information on Plenary Sessions I and II, see:
Plenary Session I: Pharmacoeconomics & Outcomes Research In Latin America>>
and

Plenary Session II: Health Care Technology Assessment (HTA): Developing & Using The Evidence In Health Care Decisions>>

The early registration deadline for this conference is July 17, 2007. For more information, see:
ISPOR 1st Latin America Conference>>

Value in Health Volume 11, Issue 1 now On-line

Value in Health Volume 11, Issue 1 is now On-line Early.
Value in Health >>

 

ISPOR CONNECTIONS Volume 13, Issue 3 Now On-Line

ISPOR CONNECTIONS Volume 13, Issue 3 is now available on-line.  Featured articles in POLICY ANALYSIS include:  "Evidence-Based Medicine (EBM) - Time for Asking Critical Questions?"   

"Evidence-Based Medicine (EBM) - Emerging Reality and Assorted Myths," and "Meta-Analysis of Complex Data via Mixed Models: Tools for Synthesizing Evidence-Based Medicine."
 

NEW

ISPOR CONNECTIONS Article Submission Site

ISPOR members can now submit their technical articles on economic analysis, policy analysis, and outcomes assessment to ISPOR CONNECTIONS on-line. Instructions to authors and an easy-to-use submission up-load system are now available at the ISPOR website at:

ISPOR CONNECTIONS>>

 

HEALTH CARE COST, QUALITY, AND OUTCOMES: ISPOR BOOK OF TERMS - NEW Discounted Price

The ISPOR Book of Terms now has new discounted prices: $20.00 for ISPOR members, $36.00 for non-members, and $15.00 for students/librarian/faculty.  For order form, see:

ISPOR Book of Terms

 

ISPOR Health Technology Assessment in Evidence-based Decision Special Interest Group (HTA SIG)

The ISPOR HTA SIG held a forum on Tuesday, May 22, 2007 at the ISPOR 12th Annual International Meeting. The forum was attended by over 600 participants and included moderator: Karl Matuszewski, MS, PharmD, Senior Director, Clinical Knowledge Service Clinical Practice Advancement Center, University HealthSystem Consortium, Oak Brook, IL, USA; and speakers: Kevin Mayo PhD, ISPOR Global Health Technology Assessments Used In Health Care Reimbursement Working Group Co-chair, and Director Health Outcomes Research Daiichi Sankyo, Inc., Parsippany, NJ, USA; Jalpa Doshi PhD, ISPOR HTA & Good Research Practices For Reimbursement Decisions Working Group Co-chair, and Research Assistant Professor, General Internal Medicine, University of Pennsylvania, Philadelphia, PA USA; and Noreen Sullivan BS,  ISPOR Health Technology Assessment of Emerging New Technologies Co-chair, and President, Aequitas, San Diego, CA USA. The presentation from the forum is now available at:

Health Technology Assessment: A Tool for Translating Evidence To Health Policy

or

ISPOR Health Technology Assessment in Evidence-based Decision Special Interest Group (HTA)

 

ISPOR Medication Compliance & Persistence Special Interest Group (MEDCOMP SIG)

The ISPOR Medication Compliance & Persistence SIG held a forum on Monday, May 21, 2007 at the ISPOR 12th Annual International Meeting. The forum was attended by over 100 participants and included moderator: Joyce Cramer BS, ISPOR Medication Compliance & Persistence SIG Chair & Research Scientist, Yale University School of Medicine, West Haven, CT, USA, and speakers Kristina Yu-Isenberg, PhD, MPH, RPh, ISPOR Analyses Standards Working Group & Director, Business Development, GlaxoSmithKline, Research Triangle Park, NC, USA;  Dyfrig Hughes PhD, MSc, ISPOR Economics of Compliance & Persistence Working Group Chair & Senior Research Fellow in Pharmacoeconomics, University of Wales, Bangor, North Wales, UK; and Femida Gwadry-Sridhar PhD, RPh, MSc, ISPOR Determinants of Compliance & Persistence Working Group Chair & Assistant Professor, University of Western Ontario & Mc Master University, Director CCR-Net & Director LHR Institute, London, ON, Canada. The presentation from the forum is now available at:

The Assessment, Costs & Determinants of Medication Compliance & Persistence | ISPOR Medication Compliance & Persistence Special Interest Group

 

The MEDCOMP SIG members also authored, “Methods for Integrating Medication Compliance and Persistence in Pharmacoeconomic Evaluations," by D. Hughes, W. Cowell, T. Koncz, and JA Cramer, which was recently published in Value in Health (Epub May 2007) See:

Methods for Integrating Medication Compliance and Persistence in Pharmacoeconomic Evaluations

 

ISPOR Avedis Donabedian Outcomes Research Lifetime Achievement Award

ISPOR is seeking nominations for the 2008 ISPOR Avedis Donabedian Outcomes Research Lifetime Achievement Award.  Nominations deadline is November 1, 2007. Nominations can be sent to: awards@ispor.org. For more information about this ISPOR award, see:

ISPOR Avedis Donabedian Outcomes Research Lifetime Achievement Award>>

 

NEW ISPOR Serbia, Slovakia, and South Africa Local Chapters

ISPOR Serbia, Slovakia, and South Africa Local Chapters were approved by the ISPOR Board of Directors in May 2007. For more information on these ISPOR chapters, see:

Serbia Local Chapter >>

South Africa Local Chapter>>

ISPOR Local Chapter Index>>

 

Journal of Managed Care Pharmacy

In association with The Academy of Managed Care Pharmacy (AMCP), ISPOR is continuing as a member service to provide access to the Journal of Managed Care Pharmacy (JMCP) to its members. For the latest issue, see:
JMCP Volume 13, Issue 4 2007 Table of Contents>>

 

ISPOR Website Tip of the Month
The ISPOR Distance Learning Program is designed to provide knowledge and skills on pharmacoeconomic and outcomes research topics (clinical, economic, humanistic, quality-of-life) via the Internet. To access, go to the 'Education' tab on the purple tool bar on the homepage and select 'Distance Learning'.

 

<< **************Advertisements*************** >>

 

Measurement, Design, and Analysis Methods for Health Outcomes Research
August 20-22, 2007
Harvard School of Public Health
Boston, MA, USA

 

Register Now!

This program is geared to introductory-intermediate learning levels to help you design, implement and analyze outcomes studies, and critically review and use outcomes data for clinical decision-making, health care planning and technology development.  Participants must have an advanced degree (e.g., MD, PhD, MS, MPH, DPharm), in a relevant discipline.

 

Who Should Attend:

  • Health care providers, administrators, and researchers who must critically review and utilize outcomes data for clinical decision-making
  • Professionals involved in health care planning, disease management programs, drug or device development and approval
  • Clinicians, nurses, and allied health professionals involved in outcomes research
  • Administrators from third party payers, benefit plan sponsors, managed care and insurance companies
  • Pharmaceutical, health care technology and biotechnology scientists, managers and executives

 

CME and CEUs Available.

 

For a detailed agenda or to register, visit:  www.hsph.harvard.edu/ccpe or call (617) 384-8690.  Please be sure to mention your Reference Code:  MDA07-IPE2 in all correspondence.

http://www.hsph.harvard.edu/ccpe/programs/MDA.shtml


 

European Health Economics

 

Health Economics Of Pharmaceuticals And Other Medical Interventions (HEPaMI 2008)

14-18 January, 18-22 February, 31 March - 4 April 200 8

Nice (Cannes), France

 

The course "HEALTH ECONOMICS OF PHARMACEUTICALS AND OTHER MEDICAL INTERVENTIONS (HEPaMI 2008)" covers: the international health care environment; theory and methods of economic evaluation of health care programs; and developments in health economic research.

 

Course Director: Gisela Kobelt, PhD, European Health Economics France and Lund University Sweden

 

Course Advisors: Professor Tony Culyer, University of York; Professor Martin Buxton, Brunel University, London, UK; Professor Bengt Jönsson, Stockholm School of Economics, Stockholm, Sweden; Professpr Gérard de Pouvourville, ESSEC, Paris, France; Professor Frans Rutten, Erasmus University, Rotterdam, The Netherlands; Professor Matthias von der Schulenburg, University of Hanover, Hanover, Germany; and Professor Adrian Towse, Office of Health Economics, London, UK.

 

International faculty will include academic health economists, regulators and government representatives, and specialists from the pharmaceutical/diagnostic/medical device industries

 

More information regarding the program can be downloaded from our website: www.he-europe.com. Enrollment is open, either directly on internet, or by mail/fax as indicated. Should you wish to discuss certain aspects of the course, or obtain more detailed explanations, please contact Gisela Kobelt, at European Health Economics, gisela.kobelt@he-europe.com or tel +33 608 075 390.

<< **************Advertisements*************** >>

This newsletter is provided as a benefit of membership in ISPOR. If you received this from a colleague and are not a current ISPOR member, please consider becoming an individual member or organizational affiliate.  Contact membership services for more information and its use in health care decisions.

 

The International Society for Pharmacoeconomics and Outcomes Research is an international organization promoting the science of pharmacoeconomics and health outcomes research.


3100 Princeton Pike, Suite 3E, Lawrenceville, NJ, 08648 USA

Tel: 609-219-0773 Toll Free: 1-800-992-0643 Fax: 609-219-0774

 

 

 

 

IMPORTANT DATES TO REMEMBER

 

17 July 2007

Early Registration Deadline:

1st Latin America Conference

More>>

 

December 1, 2007

Nominations

Deadline:

ISPOR Avedis Donabedian Outcomes Research Lifetime Achievement Award

More>>

 

QUICK LINKS

 

1st Latin America Conference

 

10th Annual European Congress

 

Other Meetings

 

Value in Health

 

ISPOR CONNECTIONS

 

ISPOR Book of Terms

 

Special Interest Groups (SIGs)

 

Student Network

 

Local Chapters

 

ISPOR Latin America Consortium

 

ISPOR Asia Consortium

 

ISPOR Asia-Pacific Medial Device & Diagnostics Council

 

Membership

 

Employment